RS

Rengarajan Sundararaman

Active Director Director DIN 09429684
DIN 09429684 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rengarajan Sundararaman

Data last updated:

Rengarajan Sundararaman is a Director at Humynd Healthcare Private Limited (since 2021). The company operates in Healthcare.

DIN 09429684
Primary Designation Director
Industry Healthcare
First Appointment 08 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Humynd Healthcare Private Limited U85200TN2021PTC148469
Director08 Dec 20212021Active

Board colleagues of Rengarajan Sundararaman

NameDINCompanyDesignation
Natarajan Nivedhitha08525323Humynd Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Humynd Healthcare Private Limited
Premium access

Shareholding and investment profile for Rengarajan Sundararaman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rengarajan Sundararaman

Rengarajan Sundararaman currently holds 1 directorship: Humynd Healthcare Private Limited (Director, since 08 Dec 2021).

Rengarajan Sundararaman was first appointed on 08 Dec 2021 as Director at Humynd Healthcare Private Limited.

The current boards of Rengarajan Sundararaman's companies include Natarajan Nivedhitha (Humynd Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available